The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Anti Obesity Drugs Market Research Report 2025

Global Anti Obesity Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1431780

No of Pages : 103

Ask Your Query

Synopsis

The global Anti Obesity Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Anti Obesity Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Obesity Drugs.

Report Scope

The Anti Obesity Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti Obesity Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti Obesity Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Pfizer
  • Merck
  • Roche
  • GlaxoSmithKline
  • AstraZeneca
  • Boehringer Ingelheim
  • Novo Nordisk
  • Eisai
  • Norgine
  • Arena Pharmaceuticals
  • Orexigen Therapeutics
  • Vivus
  • Alizyme
  • Rhythm Pharmaceuticals
  • Shionogi
  • Zafgan

Segment by Type

  • Oral Medicine
  • Diet Patch
  • Other

Segment by Application

  • Men
  • Women

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti Obesity Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti Obesity Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Anti Obesity Drugs Market Overview
1.1 Product Overview and Scope of Anti Obesity Drugs
1.2 Anti Obesity Drugs Segment by Type
1.2.1 Global Anti Obesity Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral Medicine
1.2.3 Diet Patch
1.2.4 Other
1.3 Anti Obesity Drugs Segment by Application
1.3.1 Global Anti Obesity Drugs Market Value by Application: (2024-2030)
1.3.2 Men
1.3.3 Women
1.4 Global Anti Obesity Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti Obesity Drugs Revenue 2019-2030
1.4.2 Global Anti Obesity Drugs Sales 2019-2030
1.4.3 Global Anti Obesity Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti Obesity Drugs Market Competition by Manufacturers
2.1 Global Anti Obesity Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti Obesity Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti Obesity Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Anti Obesity Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti Obesity Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti Obesity Drugs, Product Type & Application
2.7 Anti Obesity Drugs Market Competitive Situation and Trends
2.7.1 Anti Obesity Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti Obesity Drugs Players Market Share by Revenue
2.7.3 Global Anti Obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti Obesity Drugs Retrospective Market Scenario by Region
3.1 Global Anti Obesity Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti Obesity Drugs Global Anti Obesity Drugs Sales by Region: 2019-2030
3.2.1 Global Anti Obesity Drugs Sales by Region: 2019-2024
3.2.2 Global Anti Obesity Drugs Sales by Region: 2025-2030
3.3 Global Anti Obesity Drugs Global Anti Obesity Drugs Revenue by Region: 2019-2030
3.3.1 Global Anti Obesity Drugs Revenue by Region: 2019-2024
3.3.2 Global Anti Obesity Drugs Revenue by Region: 2025-2030
3.4 North America Anti Obesity Drugs Market Facts & Figures by Country
3.4.1 North America Anti Obesity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti Obesity Drugs Sales by Country (2019-2030)
3.4.3 North America Anti Obesity Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti Obesity Drugs Market Facts & Figures by Country
3.5.1 Europe Anti Obesity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti Obesity Drugs Sales by Country (2019-2030)
3.5.3 Europe Anti Obesity Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti Obesity Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti Obesity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti Obesity Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti Obesity Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti Obesity Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti Obesity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti Obesity Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anti Obesity Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti Obesity Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti Obesity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti Obesity Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti Obesity Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti Obesity Drugs Sales by Type (2019-2030)
4.1.1 Global Anti Obesity Drugs Sales by Type (2019-2024)
4.1.2 Global Anti Obesity Drugs Sales by Type (2025-2030)
4.1.3 Global Anti Obesity Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anti Obesity Drugs Revenue by Type (2019-2030)
4.2.1 Global Anti Obesity Drugs Revenue by Type (2019-2024)
4.2.2 Global Anti Obesity Drugs Revenue by Type (2025-2030)
4.2.3 Global Anti Obesity Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anti Obesity Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti Obesity Drugs Sales by Application (2019-2030)
5.1.1 Global Anti Obesity Drugs Sales by Application (2019-2024)
5.1.2 Global Anti Obesity Drugs Sales by Application (2025-2030)
5.1.3 Global Anti Obesity Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anti Obesity Drugs Revenue by Application (2019-2030)
5.2.1 Global Anti Obesity Drugs Revenue by Application (2019-2024)
5.2.2 Global Anti Obesity Drugs Revenue by Application (2025-2030)
5.2.3 Global Anti Obesity Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anti Obesity Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Anti Obesity Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Anti Obesity Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Anti Obesity Drugs Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Anti Obesity Drugs Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Anti Obesity Drugs Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Anti Obesity Drugs Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novo Nordisk Anti Obesity Drugs Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Eisai
6.8.1 Eisai Corporation Information
6.8.2 Eisai Description and Business Overview
6.8.3 Eisai Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eisai Anti Obesity Drugs Product Portfolio
6.8.5 Eisai Recent Developments/Updates
6.9 Norgine
6.9.1 Norgine Corporation Information
6.9.2 Norgine Description and Business Overview
6.9.3 Norgine Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Norgine Anti Obesity Drugs Product Portfolio
6.9.5 Norgine Recent Developments/Updates
6.10 Arena Pharmaceuticals
6.10.1 Arena Pharmaceuticals Corporation Information
6.10.2 Arena Pharmaceuticals Description and Business Overview
6.10.3 Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Arena Pharmaceuticals Anti Obesity Drugs Product Portfolio
6.10.5 Arena Pharmaceuticals Recent Developments/Updates
6.11 Orexigen Therapeutics
6.11.1 Orexigen Therapeutics Corporation Information
6.11.2 Orexigen Therapeutics Anti Obesity Drugs Description and Business Overview
6.11.3 Orexigen Therapeutics Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Orexigen Therapeutics Anti Obesity Drugs Product Portfolio
6.11.5 Orexigen Therapeutics Recent Developments/Updates
6.12 Vivus
6.12.1 Vivus Corporation Information
6.12.2 Vivus Anti Obesity Drugs Description and Business Overview
6.12.3 Vivus Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Vivus Anti Obesity Drugs Product Portfolio
6.12.5 Vivus Recent Developments/Updates
6.13 Alizyme
6.13.1 Alizyme Corporation Information
6.13.2 Alizyme Anti Obesity Drugs Description and Business Overview
6.13.3 Alizyme Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Alizyme Anti Obesity Drugs Product Portfolio
6.13.5 Alizyme Recent Developments/Updates
6.14 Rhythm Pharmaceuticals
6.14.1 Rhythm Pharmaceuticals Corporation Information
6.14.2 Rhythm Pharmaceuticals Anti Obesity Drugs Description and Business Overview
6.14.3 Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Rhythm Pharmaceuticals Anti Obesity Drugs Product Portfolio
6.14.5 Rhythm Pharmaceuticals Recent Developments/Updates
6.15 Shionogi
6.15.1 Shionogi Corporation Information
6.15.2 Shionogi Anti Obesity Drugs Description and Business Overview
6.15.3 Shionogi Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shionogi Anti Obesity Drugs Product Portfolio
6.15.5 Shionogi Recent Developments/Updates
6.16 Zafgan
6.16.1 Zafgan Corporation Information
6.16.2 Zafgan Anti Obesity Drugs Description and Business Overview
6.16.3 Zafgan Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Zafgan Anti Obesity Drugs Product Portfolio
6.16.5 Zafgan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti Obesity Drugs Industry Chain Analysis
7.2 Anti Obesity Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti Obesity Drugs Production Mode & Process
7.4 Anti Obesity Drugs Sales and Marketing
7.4.1 Anti Obesity Drugs Sales Channels
7.4.2 Anti Obesity Drugs Distributors
7.5 Anti Obesity Drugs Customers
8 Anti Obesity Drugs Market Dynamics
8.1 Anti Obesity Drugs Industry Trends
8.2 Anti Obesity Drugs Market Drivers
8.3 Anti Obesity Drugs Market Challenges
8.4 Anti Obesity Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Anti Obesity Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti Obesity Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti Obesity Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti Obesity Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti Obesity Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti Obesity Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti Obesity Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti Obesity Drugs Average Price (USD/Units) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti Obesity Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti Obesity Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti Obesity Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti Obesity Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti Obesity Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Obesity Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti Obesity Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti Obesity Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti Obesity Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Anti Obesity Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti Obesity Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Anti Obesity Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti Obesity Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Anti Obesity Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti Obesity Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Anti Obesity Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti Obesity Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti Obesity Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti Obesity Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti Obesity Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti Obesity Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti Obesity Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti Obesity Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti Obesity Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti Obesity Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti Obesity Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti Obesity Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti Obesity Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti Obesity Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti Obesity Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti Obesity Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti Obesity Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti Obesity Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti Obesity Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti Obesity Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti Obesity Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti Obesity Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti Obesity Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti Obesity Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti Obesity Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti Obesity Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Anti Obesity Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Anti Obesity Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Anti Obesity Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Anti Obesity Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti Obesity Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti Obesity Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Anti Obesity Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Anti Obesity Drugs Price (USD/Units) by Type (2019-2024)
Table 59. Global Anti Obesity Drugs Price (USD/Units) by Type (2025-2030)
Table 60. Global Anti Obesity Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Anti Obesity Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Anti Obesity Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Anti Obesity Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Anti Obesity Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti Obesity Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti Obesity Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Anti Obesity Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Anti Obesity Drugs Price (USD/Units) by Application (2019-2024)
Table 69. Global Anti Obesity Drugs Price (USD/Units) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 73. Pfizer Anti Obesity Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 78. Merck Anti Obesity Drugs Product
Table 79. Merck Recent Developments/Updates
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 83. Roche Anti Obesity Drugs Product
Table 84. Roche Recent Developments/Updates
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 88. GlaxoSmithKline Anti Obesity Drugs Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 93. AstraZeneca Anti Obesity Drugs Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Boehringer Ingelheim Corporation Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 98. Boehringer Ingelheim Anti Obesity Drugs Product
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Novo Nordisk Corporation Information
Table 101. Novo Nordisk Description and Business Overview
Table 102. Novo Nordisk Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 103. Novo Nordisk Anti Obesity Drugs Product
Table 104. Novo Nordisk Recent Developments/Updates
Table 105. Eisai Corporation Information
Table 106. Eisai Description and Business Overview
Table 107. Eisai Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 108. Eisai Anti Obesity Drugs Product
Table 109. Eisai Recent Developments/Updates
Table 110. Norgine Corporation Information
Table 111. Norgine Description and Business Overview
Table 112. Norgine Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 113. Norgine Anti Obesity Drugs Product
Table 114. Norgine Recent Developments/Updates
Table 115. Arena Pharmaceuticals Corporation Information
Table 116. Arena Pharmaceuticals Description and Business Overview
Table 117. Arena Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 118. Arena Pharmaceuticals Anti Obesity Drugs Product
Table 119. Arena Pharmaceuticals Recent Developments/Updates
Table 120. Orexigen Therapeutics Corporation Information
Table 121. Orexigen Therapeutics Description and Business Overview
Table 122. Orexigen Therapeutics Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 123. Orexigen Therapeutics Anti Obesity Drugs Product
Table 124. Orexigen Therapeutics Recent Developments/Updates
Table 125. Vivus Corporation Information
Table 126. Vivus Description and Business Overview
Table 127. Vivus Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 128. Vivus Anti Obesity Drugs Product
Table 129. Vivus Recent Developments/Updates
Table 130. Alizyme Corporation Information
Table 131. Alizyme Description and Business Overview
Table 132. Alizyme Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 133. Alizyme Anti Obesity Drugs Product
Table 134. Alizyme Recent Developments/Updates
Table 135. Rhythm Pharmaceuticals Corporation Information
Table 136. Rhythm Pharmaceuticals Description and Business Overview
Table 137. Rhythm Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 138. Rhythm Pharmaceuticals Anti Obesity Drugs Product
Table 139. Rhythm Pharmaceuticals Recent Developments/Updates
Table 140. Shionogi Corporation Information
Table 141. Shionogi Description and Business Overview
Table 142. Shionogi Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 143. Shionogi Anti Obesity Drugs Product
Table 144. Shionogi Recent Developments/Updates
Table 145. Zafgan Corporation Information
Table 146. Zafgan Description and Business Overview
Table 147. Zafgan Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 148. Zafgan Anti Obesity Drugs Product
Table 149. Zafgan Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Anti Obesity Drugs Distributors List
Table 153. Anti Obesity Drugs Customers List
Table 154. Anti Obesity Drugs Market Trends
Table 155. Anti Obesity Drugs Market Drivers
Table 156. Anti Obesity Drugs Market Challenges
Table 157. Anti Obesity Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti Obesity Drugs
Figure 2. Global Anti Obesity Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti Obesity Drugs Market Share by Type in 2023 & 2030
Figure 4. Oral Medicine Product Picture
Figure 5. Diet Patch Product Picture
Figure 6. Other Product Picture
Figure 7. Global Anti Obesity Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Anti Obesity Drugs Market Share by Application in 2023 & 2030
Figure 9. Men
Figure 10. Women
Figure 11. Global Anti Obesity Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anti Obesity Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Anti Obesity Drugs Sales (2019-2030) & (K Units)
Figure 14. Global Anti Obesity Drugs Average Price (USD/Units) & (2019-2030)
Figure 15. Anti Obesity Drugs Report Years Considered
Figure 16. Anti Obesity Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Anti Obesity Drugs Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Anti Obesity Drugs Players: Market Share by Revenue in 2023
Figure 19. Anti Obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Anti Obesity Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Anti Obesity Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Anti Obesity Drugs Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Anti Obesity Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Anti Obesity Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Anti Obesity Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Anti Obesity Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Anti Obesity Drugs Sales Market Share by Country (2019-2030)
Figure 44. Latin America Anti Obesity Drugs Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Anti Obesity Drugs Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Anti Obesity Drugs Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Anti Obesity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Anti Obesity Drugs by Type (2019-2030)
Figure 54. Global Revenue Market Share of Anti Obesity Drugs by Type (2019-2030)
Figure 55. Global Anti Obesity Drugs Price (USD/Units) by Type (2019-2030)
Figure 56. Global Sales Market Share of Anti Obesity Drugs by Application (2019-2030)
Figure 57. Global Revenue Market Share of Anti Obesity Drugs by Application (2019-2030)
Figure 58. Global Anti Obesity Drugs Price (USD/Units) by Application (2019-2030)
Figure 59. Anti Obesity Drugs Value Chain
Figure 60. Anti Obesity Drugs Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock